IRIS
LAZZARINO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.512
EU - Europa 3.353
AS - Asia 2.378
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
SA - Sud America 1
Totale 10.266
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.489
CN - Cina 2.343
IE - Irlanda 820
UA - Ucraina 799
FI - Finlandia 482
DE - Germania 399
SE - Svezia 306
IT - Italia 236
GB - Regno Unito 177
FR - Francia 89
CA - Canada 23
BE - Belgio 21
IN - India 15
NL - Olanda 10
MU - Mauritius 6
EU - Europa 5
JP - Giappone 5
RU - Federazione Russa 5
IR - Iran 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
IL - Israele 3
NG - Nigeria 3
MN - Mongolia 2
TR - Turchia 2
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
HR - Croazia 1
ID - Indonesia 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SA - Arabia Saudita 1
SG - Singapore 1
ZA - Sudafrica 1
Totale 10.266
Salva come PNG Salva come JPEG
Città #
Jacksonville 956
Chandler 922
Dublin 820
Nanjing 764
Nanchang 294
Ashburn 283
Hebei 213
Princeton 207
Lawrence 203
Shenyang 203
New York 202
Medford 196
Changsha 179
Wilmington 169
Jiaxing 155
Boardman 143
Ann Arbor 141
Beijing 118
Tianjin 116
Hangzhou 113
Helsinki 78
Milan 69
Woodbridge 52
Verona 48
Shanghai 40
Norwalk 35
Des Moines 23
Seattle 22
Brussels 21
Jinan 21
Toronto 21
Auburn Hills 17
Los Angeles 17
Fairfield 16
Kunming 16
Ningbo 16
Pavia 12
Zhengzhou 11
Pune 10
Houston 8
Lanzhou 8
Rome 8
Taizhou 8
Orange 7
Washington 7
Dearborn 6
Guangzhou 6
Andover 5
Tokyo 5
Fuzhou 4
Monmouth Junction 4
Tappahannock 4
Ardabil 3
Berlin 3
Florence 3
Mozzecane 3
Raffadali 3
Saint Paul 3
Taranto 3
Turi 3
Aragona 2
Bergamo 2
Bologna 2
Changchun 2
City of Westminster 2
Genoa 2
Gießen 2
Haikou 2
Istanbul 2
Lagos 2
Leawood 2
Manchester 2
Navi Mumbai 2
Phoenix 2
Ponte San Pietro 2
Qingdao 2
Redwood City 2
Reston 2
Taiyuan 2
Tel Aviv 2
The Bronx 2
Abuja 1
Ampang 1
Amsterdam 1
Auckland 1
Bianco 1
Bloomfield 1
Borås 1
Bulandshahr 1
Canberra 1
Capannelle 1
Chaozhou 1
Chicago 1
Chisinau 1
Chongqing 1
Clearwater 1
Como 1
Dallas 1
Dalmine 1
Frankfurt am Main 1
Totale 7.107
Salva come PNG Salva come JPEG
Nome #
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis 91
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 90
Splenic nodal and extranodal marginal zone lymphoma: features of bone marrow involvement. 85
Multiple granulocytic sarcoma during complete hematologic remission of acute nonlymphoid leukemia. 79
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. 78
Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis. 77
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndrome 76
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations 76
A low serum beta 2-microglobulin level despite bulky tumor is a characteristic feature of primary mediastinal (thymic) large B-cell lymphoma: implicatios for serologic staging. 76
Citosina arabinoside a basse dosi con o senza 1,25diidrossi vitamina D3 nella terapia delle sindromi mielodisplastiche e nele leucemie acute dell’anziano 76
Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection 75
Anemia refrattaria con eccesso di blasti : caratteristiche clinico-ematologiche ed implicazioni terapeutiche 75
Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. 72
A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma. 72
CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. 72
Analisi in citometria a flusso dei pattern differenziativi della leucemia mieloide cronica in crisi blastica. Uno studio immunofenotipico di 26 casi consecutivi 71
Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy 70
Blast phase of essential thrombocythemia: A single center study. 70
Alterazioni dell’emostasi nelle leucemie e nei tumori solidi 70
Valutazione prognostica dele sindromi mielodisplastiche 70
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial 69
Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases 68
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. 68
Chemioterapia della leucemia acuta linfoblastica dell’adulto: l’induzione della remissione e la profilassi meningea 68
Central nervous system relapse in acute promyelocytic leucemia 67
Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders 67
Lymph node reticulum cell neoplasm with progression into cytokeration-positive interstitial reticulum cell (CIRC) sarcoma: a case study 66
JAK2 (V617F) mutation in healthy individuals 66
Outcome of four patients with chronic myeloid leucemia after imatinib mesylate discontinuation. 66
Impact of advanced age on the management of acute nonlymphocytic leukemia: a study of 103 patients 66
Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia 65
Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. 64
ALK+ lymphoma: clinico-pathological findings and outcome. 63
EFFICACY OF PIPOBROMAN IN THE TREATMENT OF POLYCYTHEMIA VERA: LONG TERM RESULTS IN 163 PATIENTS 63
Long-term outcome of ph-negative acute lymphoblastic leukaemia in adults: a single centre experience. 63
Alterazioni Citogenetiche nelle sindromi mielodisplastiche 63
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 63
Pharmacokinetic behavior of Rituximab: a study of different schedules of administration for heterogeneous clinical settings. 62
Treatment of relapsed and refractory acute myloid leukemia in adults 62
Rapid response to high-dose steroids of severe bortezomib-related pulmonary complication in multiple myeloma. 61
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis 61
Immune-mediated neuropathies in myeloma patients treated with bortezomib. 61
Late onset of bortezomib-associated cutaneous reaction following herpes zoster 60
Allogeneic versus autologous BMT versus intensive post-remission chemotherapy in acute leukemias 60
Clinical characteristics and outcome of immunoglobulin M-related disorders 59
EFFICACY OF A IDARUBICIN, ETOPOSIDE AND INTERMEDIATE-DOSE CYTARABINE ARABINOSIDE AS SALVAGE THERAPY IN RELAPSING OR RESISTANT UNFAVORABLE LYMPHOMA 59
Le sindromi mielodisplastiche : molteplicita’ degli aspetti ematologici e clinici 59
Urinary proteins in multiple myeloma. correlation with clinical parameters and diagnostic implications 58
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia 58
Exaggerated insect bite-like reaction in patients affected by oncohaematological diseases 58
Impiego clinico di agenti antineoplastici ad alte dosi in oncoematologia: methotrexate e citosina arabinoside 58
Epstein-Barr Virus positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma. 58
Adult ki-1-positive large cell anaplastic lymphoma presenting with skin lesions. 58
A young woman with microcytic anemia and hypertransaminasemia 58
Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma. 57
Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence. 57
Treatment of Ph1 positive chronic myelogenous leukemia (CML) with recombinant interferon alpha 2b (Intron A) 57
Significato clinico delle alterazioni citogenetiche nelle mielodisplasie studio di 60 pazienti 57
Interferon alpha2b in the treatment of Ph1 negative myeloproliferative disoders with excessive thrombocytosis 57
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 57
Management of nodal diffuse large B-cell lymphomas : practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation 57
Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity. 56
Severe intestinal vasculitis in a patient under treatment with bortezomib. 56
Limited feasibility of double transplant in multiple myeloma: results of a multicenter study on 153 patients aged <65 years. 56
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 56
DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients 56
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. 56
Evolving approaches with alpha interferon in chronic myelogenous leukemia 56
Incidenza della monosomia 7 in corso di crisi blastica della leucemia mieloide cronica (LMC) Ph1 positiva 56
Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls 55
Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman. 55
Burkitt’s lymphoma/leukemia : a clinico-pathologic study on 24 adult patients. 55
Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myeloma 55
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 55
Ara-c ad alte dosi (HD-Ara-c) per il trattamento della malattia meningea nella leucemia acuta linfoblastica (LAL) e nei Linfomi non Hodgkin (LNH): studio di 25 casi 55
Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease 54
A striking response to bortezomib in a patient with pleural localization of multiple myeloma 54
Mielodiplasia secondarie a prgressa terapia antineoplastica 54
Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrence. 54
ABL1 amplification in T-cell acute lymphoblastic leukemia. 54
TREATMENT OF EARLY STAGE HODGKIN’S DISEASE WITH FOUR CYCLES OF ABVD FOLLOWED BY ADJUVANT RADIOTHERAPY: ANALYSIS OF EFFICACY AND LONG TERM TOXICITY 54
Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia. 54
Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma. 53
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. 53
Prognostic factors for transformation in asymptomatic immunoglobulin m monoclonal gammopathies 53
Crioglobulinemie: manifestazioni cliniche 53
Criopreservation of marrow cells for ABMT : is there any effect on the harvested leukemic cell? 53
Complicanze emorragiche e trombotiche nel paziente chirurgico 53
Etoposide : il citostatico della linea monocitica 53
Strategie per la mobilizzazione di progenitori emopoietici nel sangue periferico 53
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making 52
Primary gastric CD30 (Ki-1)positive large cell Non Hodgkin Lymphomas. A clinicopathologic analysis six cases. 52
Pathogenetic significance of “pure” monosomy 7 in myeloproliferative disorders. Analyses of 14 cases 52
First episode of acute hemolysis due to G6PD deficiency in a middle-aged woman and transmission of the enzymatic defect through bone marrow transplant 52
Mitoxantrone: clinical safety and tolerance in hematologic malignancies 52
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia 52
World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. 51
Nephrotic sindrome after allogeneic hemopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease 51
Il trapianto allogenico di cellule staminali emopoietiche dopo condizionamento non mieloablativo 51
Interferon alpha 2B (IFN2B) in the treatment of Ph1 negative chronic myeloproliferative syndromes with excessive thrombocytosis 51
Totale 6.141
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.540
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.832 823 1.206 4 145 8 161 32 169 6 218 59 1
2020/20211.357 170 131 35 143 9 182 8 197 51 197 198 36
2021/2022906 17 10 30 13 25 43 10 49 46 26 136 501
2022/20232.625 296 169 28 222 328 292 1 168 998 20 78 25
2023/20241.024 98 166 28 89 75 403 11 71 10 18 31 24
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 10.388